ProAssurance Corporation(PRA)Earnings, Financials & Key RatiosProAssurance Corporation (PRA) stock price & volume — 10-year historical chart
Investment Thesis • Updated 2026Q1
the company's inability to maintain consistent underwriting profitability, highlighted by a 102.4% combined ratio in 2025Q1, suggests that fundamental risks currently outweigh the potential for near-term margin expansion.
ProAssurance Corporation (PRA) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
ProAssurance Corporation (PRA) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 5, 2026 | $0.25vs $0.25+0.0% | $224Mvs $217M+3.1% |
| Q1 2026 | Feb 23, 2026 | $0.82vs $0.22+272.7% | $232Mvs $231M+0.6% |
| Q4 2025 | Nov 4, 2025 | $0.15vs $0.28-46.4% | $275Mvs $261M+5.3% |
| Q3 2025 | Aug 5, 2025 | $0.52vs $0.19+173.7% | $277Mvs $266M+4.1% |
Recent stock market news and headlines for ProAssurance Corporation (PRA)
NAPA, Calif., June 26, 2026 /PRNewswire/ -- The Doctors Company, the nation's largest physician-owned medical malpractice insurer, announced today that it has completed the acquisition of ProAssurance Corporation (NYSE: PRA), a specialty insurer with broad expertise in medical liability, products liability for medical technology and life sciences companies, and workers' compensation insurance.
NETSTREIT Set to Join S&P SmallCap 600 PR Newswire NEW YORK, June 24, 2026 NEW YORK
NEW YORK, June 24, 2026 /PRNewswire/ -- NETSTREIT Corp. (NYSE: NTST) will replace ProAssurance Corp. (NYSE: PRA) in the S&P SmallCap 600 effective prior to the opening of trading on Monday, June 29. The Doctors Company is acquiring ProAssurance in a cash deal expected to close soon, pending final closing conditions.
Key metrics vs top competitors for ProAssurance Corporation (PRA)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $25.00 | $1.29B | 25.25 | -2.67% | 4.64% | 3.99% | — | |
| $181.72 | $2.36B | 7.31 | 20.21% | 32.64% | 30.81% | — | |
| $142.13 | $3.77B | 19.82 | 58.16% | 20.15% | 21.74% | — | |
| $101.81 | $35.57B | 8.76 | 14.27% | 24.73% | 20.48% | — | |
| $61.78 | $5.68B | 14.17 | 6.33% | 20.8% | 22% | — | |
| $174.06 | $85.27B | 21.28 | 7.57% | 15.6% | 26.87% | — |
ProAssurance Corporation (PRA) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
ProAssurance Corporation (PRA) SEC filings — annual & quarterly reports (10-K, 10-Q)
May 5, 2026·SEC
Feb 23, 2026·SEC
Dec 8, 2025·SEC
Get notified when PRA posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
ProAssurance Corporation (PRA) stock FAQ — growth, dividends, profitability & financials explained
ProAssurance Corporation (PRA) saw revenue decline by 2.7% over the past year.
Yes, ProAssurance Corporation (PRA) is profitable, generating $65.2M in net income for fiscal year 2025 (4.6% net margin).
ProAssurance Corporation (PRA) has a return on equity (ROE) of 4.0%. This is below average, suggesting room for improvement.
ProAssurance Corporation (PRA) has a combined ratio of 93.4%. A ratio below 100% indicates underwriting profitability.
